Latest filing published 03 Mar 2023 for Kymera Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Elaine Caughey: trading record in brief
Elaine Caughey, listed as senior executive, appears in our data through filings on Kymera Therapeutics, Inc. shares, published by SEC (Form 4). In total, 4 filings cover trades dated from 1 March 2022 to 2 March 2023.
No open-market purchase appears, only 2 sales worth €21k. Besides market trades, the filings include 2 share grants. 2023 to date brings no purchases and 2 sales.
The record was last updated on 3 March 2023 with an open-market sale (€16k) in Kymera Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elaine Caughey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,557 shares0Common StockSEC:0000899243-23-006984:0
- 7,000 shares0Common StockSEC:0000899243-22-009074:0
2 of 2 declarations
